My ePortfolio Register   
Filter results by:

Showing: Disease areas / Prostate & urology

Special Issue: Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome

Abstract | Full Article | PDF Published: 30 Nov 2017 / https://doi.org/10.3332/ecancer.2017.786

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.770

Research: Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

Abstract | Full Article | PDF Published: 23 Aug 2017 / https://doi.org/10.3332/ecancer.2017.762

Case Report: Penile melanoma: a 20-Year analysis of six patients at the National Cancer Institute of Peru, Lima

Abstract | Full Article | PDF | Spanish Published: 04 Apr 2017 / https://doi.org/10.3332/ecancer.2017.731

Conference Report: Highlights from the first ecancer–Liga Colombiana contra el Cancer conference, 17–18 November 2016, Bogota, Colombia

Abstract | Full Article | PDF | Spanish Published: 28 Mar 2017 / https://doi.org/10.3332/ecancer.2017.730

Research: The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance

Abstract | Full Article | PDF Published: 10 Jan 2017 / https://doi.org/10.3332/ecancer.2017.711

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Abstract | Full Article | PDF Published: 16 Dec 2016 / https://doi.org/10.3332/ecancer.2016.703

Research: Research engagement among black men with prostate cancer

Abstract | Full Article | PDF Published: 24 Nov 2016 / https://doi.org/10.3332/ecancer.2016.695

Research: Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients

Abstract | Full Article | PDF Published: 26 Oct 2016 / https://doi.org/10.3332/ecancer.2016.682

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

Abstract | Full Article | PDF Published: 29 Sep 2016 / https://doi.org/10.3332/ecancer.2016.677



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence